Marta Garofoli

742 total citations
20 papers, 553 citations indexed

About

Marta Garofoli is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Marta Garofoli has authored 20 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Marta Garofoli's work include Blood Pressure and Hypertension Studies (12 papers), Cardiovascular Health and Disease Prevention (6 papers) and Heart Rate Variability and Autonomic Control (6 papers). Marta Garofoli is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Cardiovascular Health and Disease Prevention (6 papers) and Heart Rate Variability and Autonomic Control (6 papers). Marta Garofoli collaborates with scholars based in Italy, Colombia and United States. Marta Garofoli's co-authors include Gianpaolo Reboldi, Fabio Angeli, Paolo Verdecchia, Giovanni Mazzotta, Elisa Ramundo, Giuseppe Ambrosio, Giorgio Gentile, Claudia Bartolini, Claudia Borgioni and M Guerrieri and has published in prestigious journals such as Hypertension, Journal of the American Heart Association and Current Cardiology Reports.

In The Last Decade

Marta Garofoli

19 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Garofoli Italy 13 433 115 78 66 43 20 553
M.L. Muiesan Italy 13 389 0.9× 111 1.0× 95 1.2× 39 0.6× 36 0.8× 41 525
G Macca Italy 11 522 1.2× 113 1.0× 100 1.3× 94 1.4× 47 1.1× 16 593
Lioe-Ting Dijkhorst-Oei Netherlands 10 359 0.8× 137 1.2× 83 1.1× 40 0.6× 24 0.6× 11 602
Athanasios Kordalis Greece 13 447 1.0× 94 0.8× 85 1.1× 71 1.1× 19 0.4× 71 545
Marten E. van den Berg Netherlands 14 392 0.9× 66 0.6× 50 0.6× 69 1.0× 21 0.5× 18 665
Maurizio Salerno Italy 9 558 1.3× 122 1.1× 112 1.4× 101 1.5× 82 1.9× 12 658
Heribert Schunkert Germany 14 403 0.9× 78 0.7× 79 1.0× 44 0.7× 35 0.8× 35 502
Lothar Eckes Germany 4 584 1.3× 134 1.2× 119 1.5× 49 0.7× 24 0.6× 6 682
Arturo Lanzarotti Italy 6 507 1.2× 72 0.6× 116 1.5× 102 1.5× 31 0.7× 10 616
Guido Garavelli Italy 14 357 0.8× 165 1.4× 93 1.2× 57 0.9× 36 0.8× 23 640

Countries citing papers authored by Marta Garofoli

Since Specialization
Citations

This map shows the geographic impact of Marta Garofoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Garofoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Garofoli more than expected).

Fields of papers citing papers by Marta Garofoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Garofoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Garofoli. The network helps show where Marta Garofoli may publish in the future.

Co-authorship network of co-authors of Marta Garofoli

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Garofoli. A scholar is included among the top collaborators of Marta Garofoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Garofoli. Marta Garofoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, et al.. (2017). Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension. Journal of the American Heart Association. 6(6). 10 indexed citations
2.
Angeli, Fabio, et al.. (2015). Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Therapeutic Advances in Cardiovascular Disease. 9(6). 412–424. 58 indexed citations
3.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, & Gianpaolo Reboldi. (2013). Clinical Implications. Hypertension. 63(1). 4–4. 30 indexed citations
4.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, & Gianpaolo Reboldi. (2013). Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve. Hypertension. 63(1). 37–40. 46 indexed citations
5.
Angeli, Fabio, Gianpaolo Reboldi, Marta Garofoli, et al.. (2012). Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis. Current Cardiology Reports. 14(5). 601–610. 45 indexed citations
6.
Angeli, Fabio, Gianpaolo Reboldi, Marta Garofoli, Elisa Ramundo, & Paolo Verdecchia. (2012). Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. Acute Cardiac Care. 14(1). 34–39. 7 indexed citations
7.
Verdecchia, Paolo, Marta Garofoli, Fabio Angeli, & Gianpaolo Reboldi. (2012). Response to Morning Surge, Dipping, and Sleep-Time Blood Pressure as Prognostic Markers of Cardiovascular Risk. Hypertension. 61(1). e4–e4. 3 indexed citations
8.
Angeli, Fabio, Gianpaolo Reboldi, Giovanni Mazzotta, et al.. (2012). Fixed-Dose Combination Therapy in Hypertension. High Blood Pressure & Cardiovascular Prevention. 19(2). 51–54. 14 indexed citations
9.
Angeli, Fabio, Gianpaolo Reboldi, Giovanni Mazzotta, et al.. (2012). Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions. Current Drug Safety. 7(1). 76–85. 15 indexed citations
10.
Angeli, Fabio, et al.. (2012). Statins in acute coronary syndrome: very early initiation and benefits. Therapeutic Advances in Cardiovascular Disease. 6(4). 163–174. 18 indexed citations
11.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, et al.. (2012). Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension. Hypertension. 60(1). 34–42. 208 indexed citations
12.
Angeli, Fabio, Gianpaolo Reboldi, Giovanni Mazzotta, et al.. (2012). Fixed-Dose Combination Therapy in Hypertension. High Blood Pressure & Cardiovascular Prevention. 19(2). 51–54. 14 indexed citations
13.
Verdecchia, Paolo, Fabio Angeli, Claudio Cavallini, et al.. (2010). The Optimal Blood Pressure Target for Patients with Coronary Artery Disease. Current Cardiology Reports. 12(4). 302–306. 7 indexed citations
14.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, et al.. (2010). Aliskiren versus ramipril in hypertension. Therapeutic Advances in Cardiovascular Disease. 4(3). 193–200. 21 indexed citations
15.
Reboldi, Gianpaolo, Giorgio Gentile, Fabio Angeli, et al.. (2010). Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk. Current Cardiovascular Risk Reports. 4(2). 159–164. 2 indexed citations
16.
Verdecchia, Paolo, Fabio Angeli, Giovanni Mazzotta, et al.. (2010). Treatment strategies for osteoarthritis patients with pain and hypertension. Therapeutic Advances in Musculoskeletal Disease. 2(4). 229–240. 20 indexed citations
17.
Verdecchia, Paolo, Fabio Angeli, Claudia Borgioni, et al.. (2008). Prognostic value of circadian blood pressure changes in relation to differing measures of day and night. Journal of the American Society of Hypertension. 2(2). 88–96. 14 indexed citations
18.
Verdecchia, Paolo, Fabio Angeli, Marta Garofoli, & Gianpaolo Reboldi. (2008). The Clinical Significance of New-Onset Diabetes Mellitus in Hypertension. High Blood Pressure & Cardiovascular Prevention. 15(1). 1–3.
19.
Verdecchia, Paolo, et al.. (2008). Is the definition of daytime and nighttime blood pressure prognostically relevant?. Blood Pressure Monitoring. 13(3). 153–155. 19 indexed citations
20.
Angeli, Fabio, et al.. (2008). [Ambulatory blood pressure monitoring in clinical practice].. PubMed. 9(6). 402–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.L. Muiesan Breakdown of academic impact, for papers by G Macca Breakdown of academic impact, for papers by Lioe-Ting Dijkhorst-Oei Breakdown of academic impact, for papers by Athanasios Kordalis Breakdown of academic impact, for papers by Marten E. van den Berg Breakdown of academic impact, for papers by Maurizio Salerno Breakdown of academic impact, for papers by Heribert Schunkert Breakdown of academic impact, for papers by Lothar Eckes Breakdown of academic impact, for papers by Arturo Lanzarotti Breakdown of academic impact, for papers by Guido Garavelli
Rankless by CCL
2026